Bharath Biotech Gets CDSCO Panel Nod To Manufacture Cholera Vaccine, Inactivated, Oral for 1 year age and above Dr. Divya Colin17 April 2024 6:00 PM ISTNew Delhi: Noting the outcome of inspections of clinical trial sites conducted by the Central Drug Standard Control Organisation (CDSCO), the Subject...
Bharat Biotech, SII arm Bilthoven Biologicals collaborate to produce, supply Oral polio vaccine Ruchika Sharma3 April 2024 1:30 PM ISTThrough this collaboration, BBIL and BBio will jointly obtain the regulatory approvals and licenses required to commercially manufacture OPVs in India...
Bharat Biotech Gets CDSCO Panel Nod To Manufacture Rotavirus Vaccine Live Attenuated, Oral Dr. Divya Colin20 Jan 2024 6:00 PM ISTNew Delhi: The vaccine major Bharat Biotech has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Bharat Biotech, University of Sydney collaborate to advance vaccine research initiatives Ruchika Sharma29 Nov 2023 12:36 PM ISTHyderabad: Bharat Biotech International and the University of Sydney Infectious Diseases Institute have inked a Memorandum of Understanding (MoU)...
Revise Phase IV CT: CDSCO panel tells Bharat Biotech over Typhoid (Vi Capsular Polysaccharide) Tetanus Toxoid Conjugate Vaccine Dr. Divya Colin8 Nov 2023 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has directed the vaccine maker...
Revise phase III trial protocol: CDSCO Panel tells Bharath Biotech on Inactivated Japanese Encephalitis vaccine Dr. Divya Colin29 Sept 2023 6:00 PM ISTNew Delhi: In response to the proposal presented by vaccine maker Bharath Biotech for a grant of permission to conduct a Phase III clinical trial for...
Submit Phase III clinical trial report up to 180 days: CDSCO Panel Tells Bharat Biotech on Oral Cholera Vaccine Dr. Divya Colin30 July 2023 6:00 PM ISTNew Delhi: In response to the proposal presented by the vaccine maker Bharat Biotech to manufacture Cholera Vaccine (Inactivated, Oral), the Subject...
Design protocol as Phase III CT for 1 to more than 50 years age group: CDSCO panel tells Bharat Biotech on JE vaccine Dr. Divya Colin14 July 2023 6:00 PM ISTNew Delhi: In response to the proposal presented by the vaccine maker Bharath Biotech to conduct the Phase IV clinical trial of the Japanese...
Bharat Biotech's intranasal Covid vaccine iNCoVACC gets CDSCO Panel nod for PMS study Susmita Roy1 May 2023 6:00 PM ISTNew Delhi: In a significant development, the vaccine manufacturer Bharat Biotech International Limited has got a go-ahead from the Subject Expert...
Bharat Biotech dispatches first shipments of World's first intranasal COVID vaccine iNCOVACC across India Ruchika Sharma7 Feb 2023 3:15 PM ISTIt is a Covid19 vaccine that does not require syringes, needles, alcohol wipes, bandages, etc, saving costs related to procurement, distribution,...
State drugs regulators should be merged with CDSCO to ensure "one quality one standard": Bharat Biotech MD Ruchika Sharma6 Feb 2023 3:15 PM ISTIt is important to centralise the system, Krishna Ella said.
Bharat Biotech dispatches three lakh doses of intranasal COVID vaccine to hospitals Ruchika Sharma6 Feb 2023 10:00 AM ISTiNCOVACC is the world's first intranasal COVID-19 vaccine to receive approval for the primary 2-dose schedule, and as a heterologous booster dose for...
